Basics Fortrea Holdings Inc. Common Stock IPO Date: July 3, 2023 Sector: Healthcare Industry: Biotech Market Cap: $1.06B Activated in VL: True Average Daily Range Avg Daily Range: $0.48 | 2.58% Avg Daily Range (30 D): $0.32 | 4.17% Avg Daily Range (90 D): $0.26 | 4.27% Institutional Daily Volume Avg Daily Volume: 1.37M Avg Daily Volume (30 D): 1.56M Avg Daily Volume (90 D): 1.9M Trade Size Avg Trade Size (Sh.): 81 Avg Trade Size (Sh.) (30 D): 78 Avg Trade Size (Sh.) (90 D): 91 Institutional Trades Total Inst.Trades: 1,732 Avg Inst. Trade: $2.54M Avg Inst. Trade (30 D): $2.84M Avg Inst. Trade (90 D): $2.82M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $4.3M Avg Closing Trade (30 D): $3.03M Avg Closing Trade (90 D): $3.03M Avg Closing Volume: 249.87K     News Aug 6, 2025 @ 9:21 PM Fortrea (FTRE) Q2 Revenue Jumps 7% Source: Jesterai Aug 6, 2025 @ 10:30 AM Fortrea Reports Second Quarter 2025 Results Source: Fortrea Holdings Inc. Aug 5, 2025 @ 10:00 PM Fortrea Appoints Tracy Krumme as Senior Vice Presi... Source: Fortrea Jul 31, 2025 @ 12:10 AM FORTREA URGENT DEADLINE ALERT: Bragar Eagel & Squi... Source: Bragar Eagel & Squire, P.C. Jul 29, 2025 @ 4:00 PM DEADLINE ALERT for FTRE, VSTS: Law Offices of Howa... Source: Law Offices Of Howard G. Smith Financials   TTM Q1 2025 Q3 2024 Basic EPS $-4.14 $-6.25 $-.31 Diluted EPS $-4.14 $-6.25 $-.31 Revenue $ 710.3M $ 651.3M $ 674.9M Gross Profit $ $ $ Net Income / Loss $ -374.9M $ -562.9M $ -27.9M Operating Income / Loss $ -330.3M $ -520.1M $ -18M Cost of Revenue $ $ $ Net Cash Flow $ -20.4M $ -16.9M $ -20.9M PE Ratio